Table of Contents
1. Analyst View
2. Research Overview
3. Vaccines - An Introduction
- 3.1 History
- 3.2 Vaccine Production Stages
- 3.2.1 Cultivation
- 3.2.2 Purification
- 3.2.3 Quality Control
- 3.2.4 Packaging
- 3.3 Vaccine Approval Process
- 3.3.1 Phase I
- 3.3.2 Phase II
- 3.3.3 Phase III
- 3.3.4 Phase IV
- 3.4 Regulatory Frameworks & Intellectual Property Rights
- 3.4.1 Product Equals Process
- 3.4.2 Regulatory Requirements
- 3.4.3 Patent Protections
- 3.5 Types of Vaccine
- 3.5.1 Live Attenuated Vaccines
- 3.5.2 Killed Vaccines
- 3.5.3 Toxoid Vaccines
- 3.5.4 Component Vaccines
- 3.5.5 Genetically Engineered Vaccines
- 3.5.6 DNA Vaccines
4. Market Analysis
- 4.1 Global Vaccine Market
5. Industry Performance
- 5.1 Key Geographical Markets
- 5.1.1 US
- 5.1.2 Europe
- 5.1.3 Japan
- 5.1.4 China
- 5.1.5 India
- 5.1.6 Brazil
- 5.2 Major Vaccine Segments
- 5.2.1 Basic Pediatrics
- 5.2.2 Enhanced Pediatrics
- 5.2.3 Proprietary Pediatrics
- 5.2.4 Adult/Travel
- 5.2.5 Therapeutics
- 5.2.5.1 Cancer Vaccines
- 5.2.5.2 Addiction Vaccines
- 5.2.6 Influenza
6. Major Pediatric Vaccines
- 6.1 Pneumococcal Vaccines
- 6.2 Polio Vaccines
- 6.3 Varicella Vaccines
- 6.4 Meningitis Vaccines
- 6.5 Rotavirus Vaccines
- 6.6 DTP Vaccines
- 6.7 Measles, Mumps & Rubella (MMR) Vaccines
- 6.8 Tuberculosis Vaccines
7. Major Adult/Travel & Therapeutic Vaccines
- 7.1 Hepatitis B Vaccines
- 7.2 Malaria Vaccines
- 7.3 Japanese Encephalitis Vaccines
- 7.4 Ebola Vaccines
- 7.5 Cervical Cancer Vaccines
- 7.6 Typhoid Vaccines
- 7.7 West Nile Vaccines
- 7.8 HIV Vaccines
8. Industry Analysis
- 8.1 Market Drivers
- 8.1.1 Diseases Prevention
- 8.1.2 Higher Margins
- 8.1.3 Increased Funding from Government & NGOs
- 8.1.4 Government Regulations
- 8.1.5 Blockbuster Potential of New Vaccines
- 8.1.6 Increasing Population in Developing Countries
- 8.1.7 Disease Awareness
- 8.2 Opportunities
- 8.2.1 Contract Research
- 8.2.2 Influenza Vaccine Segment
- 8.2.3 India & China - Future Hub for Pediatric Vaccine Manufacturing
- 8.2.4 Cancer Vaccine Segment
- 8.2.5 Addiction Vaccine Segment
- 8.3 Challenges
- 8.3.1 Huge R&D Cost
- 8.3.2 Lack of Infrastructure for Trials & Manufactures
- 8.3.3 Effective Vaccine Design
- 8.3.4 Vaccine Supply
- 8.3.5 Immunization Safety
9. Vaccine Market Players
- 9.1 Major Categories
- 9.1.1 Vaccine Majors
- 9.1.2 Vaccine-focused Biotech Companies
- 9.1.3 Domestic-focused Vaccine Companies
- 9.2 Key Players
- 9.2.1 Sanofi-Aventis
- 9.2.2 GlaxoSmithKline Plc.
- 9.2.3 Merck & Co., Inc.
- 9.2.4 Novartis
- 9.2.5 Wyeth
List of Figures:
- Figure 3-1: Vaccines Horizon* (1960 to 2010)
- Figure 4-1: Global - Vaccine Market (in Billion US$), 2003-2006E
- Figure 4-2: Global - Forecast for Vaccine Market (in Billion US$),
2007-2010
- Figure 5-1: Global - Vaccine Market Segmentation by Region (%), 2005
- Figure 5-2: Global - Sales Split of Major Vaccine Player by Region (%),
2004
- Figure 5-3: US - Vaccine Market (in Billion US$), 2003, 2006E, 2008E &
2013E
- Figure 5-4: US - Pediatric Vaccine Market (in Billion US$), 2003, 2006E,
2008E & 2013E
- Figure 5-5: US - Hepatitis Vaccine Market (in Million US$), 2003, 2006E,
2008E & 2013E
- Figure 5-6: US - Biodefense Vaccine Market (in Million US$), 2003, 2006E,
2008E & 2013E
- Figure 5-7: US - Influenza Vaccine Market (in Million US$), 2003, 2006E,
2008E & 2013E
- Figure 5-8: US - Travel Vaccine Market (in Million US$), 2003, 2006E,
2008E & 2013E
- Figure 5-9: US - Developmental Vaccine Market (in Million US$), 2008E &
2013E
- Figure 5-10: Europe - Vaccine Market (in Billion US$), 2005, 2006E, 2008E
& 2012E
- Figure 5-11: Japan - Influenza Vaccine Production (in Million Units),
2004-05, 2005-06 & 2006-07E
- Figure 5-12: China - Vaccine Market (in Billion RMB) 2004-2006E
- Figure 5-13: China - Forecast for Vaccine Market (in Billion RMB) 2007-2010
- Figure 5-14: India - Vaccine Market (in Million US$) 2004-05 to 2008-09E
- Figure 5-15: India - Share of Public & Private Sectors in Vaccine Market
(%), Nov 2006
- Figure 5-16: India - Top 6 Selling Drugs in Vaccine Market (in Rs Crore),
2005-06
- Figure 5-17: India - Share of Domestic Consumption & Exports in Vaccine
Market (%), 2005-06
- Figure 5-18: Brazil - Vaccine Market (in Million BRL), 2000, 2004, 2006E &
2008E
- Figure 5-19: Brazil - Share of Public & Private Sectors in Vaccine Market
(%), 2000
- Figure 5-20: Global - Vaccine Market by Segment (in Billion US$), 2005,
2006E & 2010E
- Figure 5-21: Global - Share of Vaccine Market by Segment (%), 2005, 2006E
& 2010E
- Figure 5-22: Global - Basic Pediatrics Vaccine Market (in Billion US$),
2005 & 2006E
- Figure 5-23: Global - Forecast for Basic Pediatrics Vaccine Market (in
Billion US$), 2007-2010
- Figure 5-24: Global - Enhanced Pediatrics Vaccine Market (in Billion US$),
2005 & 2006E
- Figure 5-25: Global - Forecast for Enhanced Pediatrics Vaccine Market (in
Billion US$), 2007-2010
- Figure 5-26: Global - Proprietary Pediatrics Vaccine Market (in Billion
US$), 2005 & 2006E
- Figure 5-27: Global - Forecast for Proprietary Pediatrics Vaccine Market
(in Billion US$), 2007-2010
- Figure 5-28: Global - Adult/Travel Vaccine Market (in Billion US$), 2005 &
2006E
- Figure 5-29: Global - Forecast for Adult/Travel Vaccine Market (in Billion
US$), 2007-2010
- Figure 5-30: Global - Therapeutics Vaccine Market (in Billion US$), 2005 &
2006E
- Figure 5-31: Global - Forecast for Therapeutics Vaccine Market (in Billion
US$), 2007-2010
- Figure 5-32: Global - Cancer Vaccine Market (in Billion US$), 2005, 2008E
& 2010E
- Figure 5-33: Global - Addiction Vaccine Market (in Million US$), 2008E &
2010E
- Figure 5-34: Global - Influenza Vaccine Market (in Billion US$), 2005 &
2006E
- Figure 5-35: Global - Share of Influenza Vaccine Production by
Manufacturer (%), 2006
- Figure 5-36: Global - Forecast for Influenza Vaccine Market (in Billion
US$), 2007-2010
- Figure 6-1: Global - Pneumococcal Vaccine Market (in Billion US$), 2006 &
2010E
- Figure 6-2: Global - Number of Polio Incidences (2004-2006)
- Figure 6-3: Global - Countries with Maximum Number of Polio Incidences,
2006
- Figure 6-4: Global - Polio Vaccine Market (in Million US$), 2004 & 2011E
- Figure 6-5: Global - Inactivated Polio Vaccine Doses (in Million), 2006 &
2011F
- Figure 6-6: Global - Meningitis Vaccine Market (in Billion US$), 2004 &
2010E
- Figure 6-7: Global - Forecast for Rotavirus Vaccine Market (in Billion
US$), 2010
- Figure 6-8: Global - Forecast for Rotavirus Vaccine Market Segmentation by
Region (%), 2010
- Figure 6-9: Global - Number of Diphtheria Incidences by Region, 2006
- Figure 6-10: Global - Number of Pertussis Incidences by Region, 2006
- Figure 6-11: Global - Number of nTetanus Incidences by Region, 2006
- Figure 6-12: Global - Number of tTetanus Incidences by Region, 2006
- Figure 6-13: Global - Share of DTP Combos Market by Player (%), 2004
- Figure 6-14: Global - Number of Measles Incidences by Region, 2006
- Figure 6-15: Global - Number of Mumps Incidences by Region, 2006
- Figure 6-16: Global - Number of Rubella Incidences by Region, 2006
- Figure 6-17: Global - Number of Tuberculosis Incidences (in Thousand), 2005
- Figure 7-1: Global - Hepatitis B Surface Antigen Prevalence (%), 2005
- Figure 7-2: Global - Hepatitis B Vaccine Market (in Million US$), 1999,
2005, 2006 & 2011F
- Figure 8-1: Global - Profit Margins of Vaccines, Generics & Branded Drugs
(%), 2007E
- Figure 8-2: Global - Sources of Financing for Vaccine Market (%), 2001
- Figure 8-3: Global - Prevnar Sales (in Million US$), 2003-2006
- Figure 8-4: US - Drug Discovery Contract Research Organization Market (in
Billion US$), 2006E & 2013E
- Figure 8-5: Global - Dose Consumption & Revenue by Income of Region (%),
2005
- Figure 9-1: Global - Share of Vaccine Market by Player (%), 2005
List of Tables:
- Table 5-1: China - Vaccines Classification
- Table 5-2: China - Pediatric Vaccine Requirement (in Million Doses)
- Table 5-3: Brazil - Public & Private Sectors Vaccine Market (in Million
BRL), 2000
- Table 7-1: Global - Number of HIV/AIDS Patients (in Million), 2006
- Table 8-1: Global - Number of Deaths due to Diphtheria Averted by Vaccines
(in Thousand), 2001
- Table 8-2: Global - Cumulative Confirmed Human Cases & Number of Deaths
due to Avian Influenza A/ (H5N1), 2003-2007
- Table 9-1: Global - Share of Vaccines in Total Pharma Sales of Major
Players (%), 2005
- Table 9-2: Global - Growth of Vaccines Segment of Major Pharma Players
(%), 2005
- Table 9-3: Global - Overall Growth of Major Pharma Players (%), 2005
- Table 9-4: Global - Major Vaccine Companies (Segmentation by Revenue)
- Table 9-5: Sanofi-Aventis - Key Financials (in Million US$), 2004-2006
- Table 9-6: GlaxoSmithKline Plc. - Key Financials (in Million US$),
2004-2006
- Table 9-7: Merck & Co., Inc. - Key Financials (in Million US$), 2004-2006
- Table 9-8: Novartis - Key Financials (in Million US$), 2004-2006
- Table 9-9: Wyeth - Key Financials (in Million US$), 2004-2006
|
Related Report
|
View Cart
